Articles tagged as

Drug Manufacturers - Major

  • Showing 1-100 of 124 items
  • 1
  • 2
  • >>
  1. Top 6 Pharmaceutical Companies Globally

  2. Who Is Driving Pfizer's Management Team? (PFE)

  3. Top 5 Drug Stocks of 2016 (ABBV, JNJ)

  4. Who Is Driving Novarti's Management Team? (NVS, BAYRY)

  5. Top 5 Pharmaceutical Stocks of 2016 (ABBV, JNJ)

  6. Top 5 Corporate Donors in Big Pharma (GILD, MRK)

  7. Behind Johnson & Johnson's 91.5% Rise in 10 years (JNJ)

  8. FPHAX: Mutual Fund to Invest in Pharmaceuticals by Fidelity

  9. Opko's mangement and pipeline makes it a solid buy (OPK)

  10. Relypsa: How The Bulls and Bears are Both Right

  11. Valeant: Why Drug Price Cuts Not Seen Yet (VRX, WBA)

  12. Positive FDA Committee Vote on Vantrela Bodes Well for Remoxy

  13. Big Pharma: Will Price Pressure Happen No Matter What?

  14. The Share Buyback Report: Health Care Sector (PFE, JNJ)

  15. Important Catalysts Approaching for These Biotechs

  16. 4 Lessons Valeant Can Teach Investors (VRX)

  17. The Industry Handbook: Pharma Industry

  18. 3 Catalysts That Will Drive AERI Higher in 2016 (AERI, VRX)

  19. (ADHD) Who are Alcobra's Main Competitors?

  20. Gilead Stock: Analyzing 3 Key Customers (GILD)

  21. CVS Stock Rises on 20% Surge in Q1 Revenue (CVS)

  22. 6 Reasons to Watch Kythera Biopharm Inc. (AGN, PFE)

  23. Gilead Stock: Analyzing 5 Key Suppliers (GILD)

  24. (VRX) Who are Valeant's Main Competitors?

  25. Top 3 Companies Owned by Valeant (VRX)

  26. Singer Gets Better End of AGN-PFE Deal Implosion

  27. Is it too Late to Invest in Synergy Pharmaceuticals? (SGYP)

  28. Is there any Upside in Neurocine Biosciences, Inc? (NBIX)

  29. The 5 Highest Paid Executives in the Healthcare Sector (AGN, PFE)

  30. Has Gilead Sciences Become a Value Stock? (GILD)

  31. 4 Reasons Behind Bill Ackman's Purchase of Zoetis Stock (ZTS, PFE)

  32. Is Big Pharma Under Pressure in 2016? (JNJ, GSK)

  33. Novo Nordisk: The Drug Firm You've Yet to Hear Of

  34. Gilead's 3 Most Profitable Lines of Business (GILD)

  35. Johnson & Johnson's Partnership with Nextera (JNJ)

  36. Analyzing Pfizer's Return on Equity (ROE) (PFE)

  37. The Cancer (and Other Drug) Shortage

  38. Celgene's 3 Key Financial Ratios (CELG)

  39. 3 Drugs That Could Bankrupt Medicare (GILD)

  40. Pfizer's 3 Key Financial Ratios (PFE)

  41. Johnson & Johnson's 3 Key Financial Ratios (JNJ)

  42. Analyzing Amgen's Debt Ratios in 2016 (AMGN)

  43. Top 5 Positions in Dodge & Cox's Portfolio (HPQ, SLB)

  44. Is Pfizer Stock Suitable for Your IRA or Roth IRA? (PFE)

  45. Amgen: An Activist Investment Analysis (AMGN)

  46. Analyzing Amgen's Price & Profitability Ratios in 2016 (AMGN)

  47. How Soon Will We Get a Zika Vaccine?

  48. Gilead's 3 Key Financial Ratios (GILD)

  49. How Medtronic Makes Money (MDT)

  50. Yo Shkreli: Kanye Doesn't Want Your $10M, Bromance

  51. Forest Laboratories: An Activist Investment Analysis

  52. Zika: Study Says This Device Could Protect You

  53. How Pharmaceutical Companies Price Their Drugs

  54. Jana Partners: An Activist Investor Analysis

  55. The Biggest Risks of Investing in Johnson & Johnson Stock (JNJ)

  56. The Biggest Risks of Investing in Celgene Stock (CELG)

  57. In Pain? Sanofi Has a Cure for That (SNY)

  58. Allergan: An Activist Investment Analysis (AGN,VRX)

  59. JNJ vs. PG: Which is the Better Bet Right Now?

  60. 2016's Most Promising Stocks (INTC, IBM)

  61. Novartis Stock: A Dividend Analysis (NVS)

  62. How Novartis Probably Has a Cure for What Ails You

  63. Are These the Top Biotech Stocks of 2016?

  64. How the New Allergan Plc Will Make Money

  65. Healthcare Stocks: Are These 2016's Best?

  66. Is Johnson & Johnson Stock Suitable for Your IRA or Roth IRA? (JNJ)

  67. The Top 5 Health Care ETFs for 2016 (XLV, VHT)

  68. The Top 5 Large-Cap Healthcare Stocks for 2016 (GILD, ANTM)

  69. PJP: PowerShares Dynamic Pharmaceuticals ETF

  70. The World's Top 10 Biotechnology Companies (JNJ, ROG.VX)

  71. CURE: Direxion Daily Healthcare Bull 3X ETF

  72. PPH: Market Vectors Pharmaceutical ETF

  73. Roche Stock: A Dividend Analysis

  74. 3 of America's Most Expensive Drugs and Who Profits From Them

  75. 4 Reasons Gilead Sciences Should be in Your Stock Portfolio (GILD)

  76. The Biggest Risks of Investing in Pfizer Stock (PFE)

  77. Johnson & Johnson Stock: A Dividend Analysis (JNJ)

  78. This Resilient Stock Should be on Your Watch List

  79. The 5 Best Dividend Stocks in the Healthcare Sector (GSK, ABBV)

  80. Top 5 Health Mutual Funds

  81. Should You Avoid Biotech Stocks Right Now? (LABD, IBB)

  82. 4 Trends Driving M&A in the Healthcare Industry in 2015

  83. Are Drug Price Controls Viable in the U.S.? (IPXL, ABBV)

  84. Healthcare M&A and Prescription Drug Prices

  85. Valeant Pharmaceuticals acquires Sprout Pharmaceuticals (VRX)

  86. Is the Ebola Epidemic Officially Over?

  87. Sarepta Therapeutics Made Investors Millionaires in 2 Years

  88. Celgene Vs. Gilead: Vetting for the Best Biopharma

  89. Make Room for Exelixis in Your Portfolio

  90. Drugmaker Extraordinaire: How Eli Lilly Grows

  91. Are Bears About to Burst the Biotech Bubble? (IBB, BIB)

  92. Pfizer CEO: The Story Behind Ian Read (PFE, AZN)

  93. 10 Developments By Gilead Sciences That Could Boost Profits (GILD)

  94. Are These 2015's 10 Best Generic Pharma Stocks?

  95. How to Profit from the Generic Drug Trend

  96. From Startup To Blue Chip: The Success Story Of Gilead Sciences Inc.

  97. Top 10 Pfizer Venture Investments (PFE)

  98. Is It Too Late To Invest In Gilead Sciences? (GILD)

  99. How Does Biogen Make its Money?

  100. Small-Cap Biotech Stocks to Watch

  • Showing 1-100 of 124 items
  • 1
  • 2
  • >>
Trading Center